Structure Therapeutics CSO Lin Xichen reports disposal of common shares worth $207,378.61
Reuters2026/08/20 00:23- Structure Therapeutics Chief Scientific Officer Lin Xichen exercised share options for 11,817 ordinary shares at USD 0.34 on Aug. 18, 2026.
- Those shares were converted into 3,939 American Depositary Shares.
- Lin sold 3,939 American Depositary Shares on Aug. 18 at weighted-average prices of USD 53.13, USD 54.2, USD 55.05.
- Directly held ordinary shares fell to 228,960; share options outstanding declined to 142,898.
- Lin ended the day with no American Depositary Shares.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
TRUMP reached a peak of 1.86 USDT this morning, up 25.07% in 24 hours.
After the earnings fiasco, OpenAI CFO urgently reassures staff at an all-hands meeting: Q3 ARR has increased by 35%, and the company may go public in 2027 or even earlier.
Facing dual pressures of only 18% revenue growth in Q2 and successive executive departures, OpenAI’s CFO disclosed in an all-hands meeting the latest Q3 data: overall ARR has grown by 35% to date, while enterprise ARR has increased by 50%. She also stated clearly that the company “will go public by 2027 or earlier.” Additionally, she assured employees not to worry about Anthropic possibly going public first, saying, “We are running our own race.”
PDG Realty says RBZA Consultoria Imobiliaria takes 5.02% stake
2-Yr Benchmark Govt Yields - Germany vs Other Nations
